New research study for patients with Type 2 Diabetes who are not currently taking insulin

About the Study

This study is for individuals with Type 2 Diabetes who are currently not taking insulin. Participants will add either a once-weekly long-acting investigational insulin or an approved daily long-acting insulin to their current diabetes treatment. The goal of the study is to compare the investigational weekly insulin and approved daily insulin by looking at changes in A1C over the course of the study.

Participant Eligibility Criteria ( To take part in the study )

• Adults with Type 2 Diabetes 
• A1C between 7.0 and 10.0%
• Have not used insulin for diabetes treatment